{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:57:29Z","timestamp":1791050249232,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004482","name":"Kuwait University","doi-asserted-by":"publisher","award":["MA01\/08"],"award-info":[{"award-number":["MA01\/08"]}],"id":[{"id":"10.13039\/501100004482","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.neuropharm.2013.09.013","type":"journal-article","created":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T00:46:31Z","timestamp":1379983591000},"page":"100-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["(\u2212)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats"],"prefix":"10.1016","volume":"77","author":[{"given":"Waleed M.","family":"Renno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanim","family":"Al-Khaledi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyaa","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaima M.","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Abul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Asfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"47","key":"10.1016\/j.neuropharm.2013.09.013_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/glia.20047","article-title":"Nestin expression in hippocampal astrocytes after injury depends on the age of the hippocampus","volume":"2004","author":"Abdel-Rahman","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ar.20678","article-title":"Alteration of glial fibrillary acidic proteins immunoreactivity in astrocytes of the spinal cord diabetic rats","volume":"291","author":"Afsari","year":"2008","journal-title":"Anatomical Rec. (Hoboken)"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib3","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.4049\/jimmunol.173.9.5794","article-title":"Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis","volume":"173","author":"Aktas","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib4","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/00006123-199905000-00052","article-title":"Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury","volume":"44","author":"Amar","year":"1999","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2119\/2004-00032.Aneja","article-title":"Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats","volume":"10","author":"Aneja","year":"2004","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/exnr.2001.7699","article-title":"Pegylated brain-derived neurotrophic factor shows improved distribution into the spinal cord and stimulates locomotor activity and morphological changes after injury","volume":"170","author":"Ankeny","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib8","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1089\/neu.2006.0172","article-title":"Delayed transplantation with exogenous neurotrophin administration enhances plasticity ofncorticofugal projections after spinal cord injury","volume":"24","author":"arikov","year":"2007","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/neu.1995.12.1","article-title":"A\u00a0sensitive and reliable locomotor rating scale for open field testing in rats","volume":"12","author":"Basso","year":"1995","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/neu.1996.13.343","article-title":"MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter animal spinal cord injury Study","volume":"13","author":"Basso","year":"1996","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/WCO.0b013e32834c208d","article-title":"Inflammation and axon regeneration","volume":"24","author":"Benowitz","year":"2011","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0079-6123(02)37020-1","article-title":"Transplants and neurotrophic factors increase regeneration and recovery of function after spinal cord injury","volume":"137","author":"Bregman","year":"2002","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/10790268.2008.11760720","article-title":"Novel combination strategies to repair the injured mammalian spinal cord","volume":"31","author":"Bunge","year":"2008","journal-title":"J.\u00a0Spinal Cord Med."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s11999-010-1674-0","article-title":"Spinal cord injury: a systematic review of current treatment options","volume":"469","author":"Cadotte","year":"2011","journal-title":"Clin. Orthop. Rela.T Res."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.expneurol.2010.12.023","article-title":"Delayed treatment with chondroitinase ABC reverses chronic atrophy of rubrospinal neurons following spinal cord injury","volume":"228","author":"Carter","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib17","first-page":"1045","article-title":"Absorption, distribution, elimination of tea polyphenols in rats","volume":"25","author":"Chen","year":"1997","journal-title":"Drug Metab. Dispos"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brainres.2004.05.079","article-title":"Protective effect of epigallocatechin gallate on brain damage after transient middle cerebral artery occlusion in rats","volume":"1019","author":"Choi","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/neu.2006.23.1","article-title":"Locomotor deficits and adaptive mechanisms after thoracic spinal cord contusion in the adult rat","volume":"23","author":"Collazos-Castro","year":"2006","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib20","doi-asserted-by":"crossref","first-page":"9334","DOI":"10.1523\/JNEUROSCI.21-23-09334.2001","article-title":"Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins","volume":"21","author":"Coumans","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00441-012-1430-8","article-title":"Role of phospholipase A2s and lipid mediators in secondary damage after spinal cord injury","volume":"349","author":"David","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2004.03.051","article-title":"Pharmacological characterization of the chronic constriction injury model of neuropathic pain","volume":"491","author":"De Vry","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.expneurol.2008.04.009","article-title":"Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats","volume":"212","author":"Detloff","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib25","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1460-9568.1994.tb00983.x","article-title":"Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord","volume":"6","author":"Dusart","year":"1994","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.nbd.2012.05.001","article-title":"Microglial inhibitory factor (MIF\/TKP) mitigates secondary damage following spinal cord injury","volume":"47","author":"Emmetsberger","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/10790268.2007.11753926","article-title":"Functional recovery in rats with chronic spinal cord injuries after exposure to an enriched environment","volume":"30","author":"Fischer","year":"2007","journal-title":"J.\u00a0Spinal Cord Med."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.expneurol.2004.01.032","article-title":"Partial recovery after treatment of chronic paraplegia in rat","volume":"188","author":"Fraidakis","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib30","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/syn.20903","article-title":"Combination strategies for repair, plasticity, and regeneration using regulation of gene expression during the chronic phase after spinal cord injury","volume":"65","author":"Gerin","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1089\/neu.2006.23.263","article-title":"Degenerative and spontaneous regenerative processes after spinal cord injury","volume":"23","author":"Hagg","year":"2006","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.expneurol.2008.07.016","article-title":"Gliopathy ensures persistent inflammation and chronic pain after spinal cord injury","volume":"214","author":"Hulsebosch","year":"2008","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2013.09.013_bib33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainresrev.2008.12.010","article-title":"Mechanisms of chronic central neuropathic pain after spinal cord injury","volume":"60","author":"Hulsebosch","year":"2009","journal-title":"Brain Res. Rev. Apr"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib34","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.transproceed.2006.06.101","article-title":"Polyphenol (\u2212)-epigallocatechin gallate protection from ischemia\/reperfusion-induced renal injury in normotensive and hypertensive rats","volume":"38","author":"Jang","year":"2006","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuron.2009.09.016","article-title":"Combined intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration one year after spinal cord injury","volume":"64","author":"Kadoya","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.canlet.2005.10.021","article-title":"Dual function of (\u2212)-epigallocatechin gallate (EGCG) in healthy human lymphocytes","volume":"241","author":"Kanadzu","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib37","doi-asserted-by":"crossref","first-page":"e11951","DOI":"10.1371\/journal.pone.0011951","article-title":"Dual beneficial effects of (\u2212)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in\u00a0vitro and in\u00a0vivo studies","volume":"5","author":"Kang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12035-012-8287-4","article-title":"Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects","volume":"46","author":"Karimi-Abdolrezaee","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib39","first-page":"31","article-title":"Anti-inflammatory effect of the epigallocatechin gallate following spinal cord trauma in rat","volume":"15","author":"Khalatbary","year":"2011","journal-title":"Iran Biomed. J."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.brainres.2009.09.109","article-title":"Effects of epigallocatechin gallate on tissue protection and functional recovery after contusive spinal cord injury in rats","volume":"1306","author":"Khalatbary","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib41","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.febslet.2006.02.052","article-title":"Epigallocatechin-3-gallate protects toluene diisocyanate-induced airway inflammation in a murine model of asthma","volume":"580","author":"Kim","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1089\/neu.2005.22.214","article-title":"The assessment of locomotor function in spinal cord injured rats: the importance of objective analysis of coordination","volume":"22","author":"Koopmans","year":"2005","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/jpet.109.156034","article-title":"Thermal hyperalgesia via supraspinal mechanisms in mice lacking glutamate decarboxylase 65","volume":"331","author":"Kubo","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01159-9","article-title":"Protective effects of the green tea polyphenol (\u2212)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils","volume":"287","author":"Lee","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib45","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ptr.1090","article-title":"Protective effect of green tea polyphenol (\u2212)-epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates","volume":"17","author":"Lee","year":"2003","journal-title":"Phytother. Res."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib46","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0361-9230(03)00139-4","article-title":"Effects of delayed administration of (\u2212)-epigallocatechin gallate, a green tea polyphenol on the changes in polyamine levels and neuronal damage after transient forebrain ischemia in gerbils","volume":"61","author":"Lee","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib47","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jnr.20193","article-title":"Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils","volume":"77","author":"Lee","year":"2004","journal-title":"J.\u00a0Neurosc.I Res."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib48","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1440-1681.2004.04044.x","article-title":"(\u2212)-Epigallocatechin gallate attenuates glutamate-induced cytotoxicity via intracellular Ca modulation in PC12 cells","volume":"31","author":"Lee","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib49","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1089\/neu.2011.1860","article-title":"Prevention of both neutrophil and monocyte recruitment promotes recovery after spinal cord injury","volume":"28","author":"Lee","year":"2011","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib50","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1523\/JNEUROSCI.23-10-04219.2003","article-title":"Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury","volume":"23","author":"Li","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib51","first-page":"376","article-title":"Epigallocatechin gallate protects dopaminergic neurons against 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by inhibiting microglial cell activation","volume":"26","author":"Li","year":"2006","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib52","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/01902148.2011.584359","article-title":"Green tea epigallo-catechin-galleate ameliorates the development of obliterative airway disease","volume":"37","author":"Liang","year":"2011","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib53","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/art.23937","article-title":"Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase\/Akt\/Raf-1 interaction: a potential therapeutic benefit for arthritis","volume":"58","author":"Lin","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.expneurol.2006.07.030","article-title":"Axon regeneration through scars and into sites of chronic spinal cord injury","volume":"203","author":"Lu","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.expneurol.2006.04.035","article-title":"Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury","volume":"201","author":"Macias","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000085385","article-title":"Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway","volume":"14","author":"Mandel","year":"2005","journal-title":"Neurosignals"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/neu.2000.17.1","article-title":"Validation of the weight-drop contusion model in rats: a comparative study of human spinal cord injury","volume":"17","author":"Metz","year":"2000","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib58","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0006-8993(00)02778-5","article-title":"Efficient testing of motor function in spinal cord injured rats","volume":"883","author":"Metz","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib59","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1742-2094-9-100","article-title":"Spatial and temporal correlation in progressive degeneration of neurons and astrocytes in contusion-induced spinal cord injury","volume":"9","author":"Min","year":"2012","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib60","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1471-4159.2005.03462.x","article-title":"Transcriptional profiling of spinal cord injury-induced central neuropathic pain","volume":"95","author":"Nesic","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib61","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.expneurol.2006.02.123","article-title":"Delayed treatment with Rho-kinase inhibitor does not enhance axonal regeneration or functional recovery after spinal cord injury in rats","volume":"200","author":"Nishio","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib62","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1046\/j.1460-9568.2000.00978.x","article-title":"Survival effects of BDNF and NT-3 on axotomized rubrospinal neurons depend on the temporal pattern of neurotrophin administration","volume":"12","author":"Novikova","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2013.09.013_bib63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13311-011-0036-2","article-title":"Novel neuroinflammatory targets in the chronically injured spinal cord","volume":"8","author":"Pajoohesh-Ganji","year":"2011","journal-title":"Neurotherapeutics. Apr"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib64","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00000542-199902000-00027","article-title":"Intrathecal clonidine alleviates allodynia in neuropathic rats: interaction with spinal muscarinic and nicotinic receptors","volume":"90","author":"Pan","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib65","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mcn.2005.09.001","article-title":"MICAL flavoprotein monooxygenases: expression during neural development and following spinal cord injuries in the rat","volume":"31","author":"Pasterkamp","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib66","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00210-009-0414-z","article-title":"Treatment with green tea extract attenuates secondary inflammatory response in an experimental model of spinal cord trauma","volume":"380","author":"Paterniti","year":"2009","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib67","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1097\/00007632-199609150-00002","article-title":"The injured spinal cord: imaging, histopathologic clinical correlates, and basic science approaches to enhancing neural function after spinal cord injury","volume":"21","author":"Quencer","year":"1996","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib68","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neulet.2005.03.018","article-title":"(\u2212)-Epigallocatechin gallate as an intervention for the acute treatment of cerebral ischemia","volume":"382","author":"Rahman","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib69","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/35067570","article-title":"Plasticity of motor systems after incomplete spinal cord injury","volume":"2","author":"Raineteau","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10284150600576705","article-title":"Green tea pain modulating effect in sciatic nerve chronic constriction injury rat model","volume":"9","author":"Renno","year":"2006","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib71","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1179\/147683008X301405","article-title":"Consumption of green tea alters glial fibriliary acidic protein immunoreactivity in the spinal cord astrocytes of STZ-diabetic rats","volume":"11","author":"Renno","year":"2008","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib72","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00210-012-0758-7","article-title":"(\u2212)-Epigallocatechin-3-gallate (EGCG) attenuates functional deficits and morphological alterations by diminishing apoptotic gene overexpression in skeletal muscles after sciatic nerve crush injury","volume":"385","author":"Renno","year":"2012","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib73","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neuint.2012.12.018","article-title":"(\u2212)-Epigallocatechin-3-gallate (EGCG) attenuates peripheral nerve degeneration in rat sciatic nerve crush injury","volume":"62","author":"Renno","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib74","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s11064-011-0414-5","article-title":"Upregulation of inflammatory mediators in a model of chronic pain after spinal cord injury","volume":"36","author":"Sandhir","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib75","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/neu.2006.23.521","article-title":"Long-term care of paraplegic laboratory mammals","volume":"23","author":"Santos-Benito","year":"2006","journal-title":"J.\u00a0Neurotrauma."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib76","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1089\/08977150260338038","article-title":"A\u00a0statistical method for analyzing rating scale data: the BBB locomotor score","volume":"19","author":"Scheff","year":"2002","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib77","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sc.2010.129","article-title":"Post-mortem assessment of rat spinal cord injury and white matter sparing using inversion recovery-supported proton density magnetic resonance imaging","volume":"49","author":"Scholtes","year":"2011","journal-title":"Spinal Cord"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib78","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1152\/physrev.1996.76.2.319","article-title":"Degeneration and regeneration of axons in the lesioned spinal cord","volume":"76","author":"Schwab","year":"1996","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib79","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/path.4106","article-title":"Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer \u2018if\u2019 but \u2018how\u2019","volume":"229","author":"Shechter","year":"2013","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib80","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0165-5728(03)00253-4","article-title":"Peripheral nerve induces macrophage neurotrophic activities: regulation of neuronal process outgrowth, intracellular signaling and synaptic function","volume":"142","author":"Shibata","year":"2003","journal-title":"J.\u00a0Neuroimmunol"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib81","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10571-012-9828-0","article-title":"Effects of swim stress and fluoxetine on 5-HT1A receptor gene expression and monoamine metabolism in the rat brain regions","volume":"32","author":"Shishkina","year":"2012","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib82","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1089\/neu.2006.23.1654","article-title":"The Louisville Swim Scale: a novel assessment of hindlimb function following spinal cord injury in adult rats","volume":"23","author":"Smith","year":"2006","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib83","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1074\/mcp.R900003-MCP200","article-title":"Neuroproteomics approaches to decipher neuronal regeneration and degeneration","volume":"9","author":"Sun","year":"2010","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib84","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/neu.2010.1533","article-title":"Effect of vascular endothelial growth factor treatment in experimental traumatic spinal cord injury: in\u00a0vivo longitudinal assessment","volume":"28","author":"Sundberg","year":"2011","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2013.09.013_bib85","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0027-5107(01)00183-X","article-title":"Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation","volume":"480-481","author":"Surh","year":"2001","journal-title":"Mutat. Res."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib86","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1096\/fj.04-2806fje","article-title":"Neuroprotective effects of (\u2212)-epigallocatechin gallate following hypoxia-ischemia-induced brain damage: novel mechanisms of action","volume":"19","author":"Sutherland","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib87","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jnutbio.2005.10.005","article-title":"Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration","volume":"17","author":"Sutherland","year":"2006","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib88","first-page":"BR166","article-title":"Protective effects of green tea catechins on cerebral ischemic damage","volume":"10","author":"Suzuki","year":"2004","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib89","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1750-3639.1995.tb00619.x","article-title":"Update on the pathophysiology and pathology of acute spinal cord injury","volume":"5","author":"Tator","year":"1995","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib90","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s11064-013-0976-5","article-title":"Intrathecal epigallocatechin gallate treatment improves functional recovery after spinal cord injury by upregulating the expression of BDNF and GDNF","volume":"38","author":"Tian","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib91","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1096\/fj.04-1716fje","article-title":"Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia\/reperfusion-induced apoptosis","volume":"18","author":"Townsend","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib92","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbrc.2011.02.010","article-title":"Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase\/mTOR inhibitor","volume":"406","author":"Van Aller","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib93","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jnutbio.2006.03.004","article-title":"Green tea catechins inhibit pancreatic phospholipase A(2) and intestinal absorption of lipids in ovariectomized rats","volume":"17","author":"Wang","year":"2006","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1423-0127-18-13","article-title":"Reduction in antioxidant enzyme expression and sustained inflammation enhance tissue damage in the subacute phase of spinal cord contusive injury","volume":"18","author":"Wang","year":"2011","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib95","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12263-009-0143-4","article-title":"Neuroprotective molecular mechanisms of (\u2212)-epigallocatechin-3-gallate: a reflective outcome of its\u00a0antioxidant, iron chelating and neuritogenic properties","volume":"4","author":"Weinreb","year":"2009","journal-title":"Genes Nutr."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib96","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0079-6123(02)37019-5","article-title":"Spinal cord contusion models","volume":"137","author":"Young","year":"2002","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib97","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.febslet.2010.05.011","article-title":"Epigallocatechin-3-gallate protects motor neurons and regulates glutamate level","volume":"584","author":"Yu","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2013.09.013_bib98","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.expneurol.2007.04.013","article-title":"Expression changes of growth-associated protein-43 (GAP-43) and mitogen-activated protein kinase phosphatase-1 (MKP-1) and in hippocampus of Streptozotocin-inducted diabetic cognitive impairment rats","volume":"206","author":"Zhou","year":"2007","journal-title":"Exp. Neurol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813004206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813004206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T11:00:34Z","timestamp":1617620434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813004206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":95,"alternative-id":["S0028390813004206"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.09.013","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"(\u2212)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}